Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biochemistry|October 29, 2003
High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clientsBradley T Scroggins, Thomas Prince, Jieya Shao, et al.The Journal of Biological Chemistry|February 15, 2015
Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1Marc I Diamond, Shirong Cai, Aaron Boudreau, et al.Cell Reports|June 11, 2020
Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast CancerCuige Zhu, Anna Rogers, Karama Asleh, et al.Cell Reports|February 17, 2021
Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1Cuige Zhu, Sun-Joong Kim, Arshag Mooradian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast CancerSuzanne E Wardell, Matthew J Ellis, Holly M Alley, et al.Science Signaling|August 10, 2017
Breast tumors educate the proteome of stromal tissue in an individualized but coordinated mannerXuya Wang, Arshag D Mooradian, Petra Erdmann-Gilmore, et al.Oncogene|May 12, 2018
Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targetsLeah A Gates, Guowei Gu, Yue Chen, et al.Cell Reports|August 9, 2018
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerJonathan T Lei, Jieya Shao, Jin Zhang, et al.Cell Reports|September 24, 2013
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenograftsShunqiang Li, Dong Shen, Jieya Shao, et al.Pageof 3